TuHURA Biosciences (HURA) Competitors $2.22 -0.07 (-3.06%) Closing price 04:00 PM EasternExtended Trading$2.22 -0.01 (-0.23%) As of 05:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock HURA vs. ZYBT, ORKA, SIGA, CMPS, PGEN, TRML, RGNX, PRTC, KMDA, and ORGOShould you be buying TuHURA Biosciences stock or one of its competitors? The main competitors of TuHURA Biosciences include Zhengye Biotechnology (ZYBT), Oruka Therapeutics (ORKA), Siga Technologies (SIGA), COMPASS Pathways (CMPS), Precigen (PGEN), Tourmaline Bio (TRML), REGENXBIO (RGNX), PureTech Health (PRTC), Kamada (KMDA), and Organogenesis (ORGO). These companies are all part of the "pharmaceutical products" industry. TuHURA Biosciences vs. Its Competitors Zhengye Biotechnology Oruka Therapeutics Siga Technologies COMPASS Pathways Precigen Tourmaline Bio REGENXBIO PureTech Health Kamada Organogenesis TuHURA Biosciences (NASDAQ:HURA) and Zhengye Biotechnology (NASDAQ:ZYBT) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, dividends, institutional ownership, analyst recommendations, earnings and valuation. Is HURA or ZYBT more profitable? TuHURA Biosciences' return on equity of 291.69% beat Zhengye Biotechnology's return on equity.Company Net Margins Return on Equity Return on Assets TuHURA BiosciencesN/A 291.69% 122.09% Zhengye Biotechnology N/A N/A N/A Do analysts rate HURA or ZYBT? TuHURA Biosciences presently has a consensus price target of $12.67, indicating a potential upside of 470.57%. Given TuHURA Biosciences' stronger consensus rating and higher possible upside, equities analysts clearly believe TuHURA Biosciences is more favorable than Zhengye Biotechnology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TuHURA Biosciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.40Zhengye Biotechnology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer HURA or ZYBT? In the previous week, TuHURA Biosciences had 15 more articles in the media than Zhengye Biotechnology. MarketBeat recorded 17 mentions for TuHURA Biosciences and 2 mentions for Zhengye Biotechnology. Zhengye Biotechnology's average media sentiment score of 0.93 beat TuHURA Biosciences' score of 0.55 indicating that Zhengye Biotechnology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TuHURA Biosciences 3 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive Zhengye Biotechnology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals believe in HURA or ZYBT? 0.6% of TuHURA Biosciences shares are held by institutional investors. 0.2% of TuHURA Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has preferable valuation and earnings, HURA or ZYBT? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTuHURA BiosciencesN/AN/A-$21.68MN/AN/AZhengye BiotechnologyN/AN/AN/AN/AN/A SummaryTuHURA Biosciences beats Zhengye Biotechnology on 9 of the 10 factors compared between the two stocks. Get TuHURA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HURA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HURA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HURA vs. The Competition Export to ExcelMetricTuHURA BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$96.97M$2.82B$5.42B$8.91BDividend YieldN/A2.71%5.36%4.18%P/E RatioN/A21.0225.9919.61Price / SalesN/A281.89384.75104.96Price / CashN/A43.1936.0256.31Price / Book6.537.207.875.45Net Income-$21.68M-$55.15M$3.15B$248.88M7 Day Performance-12.94%0.76%3.13%3.09%1 Month Performance-24.49%6.55%6.04%4.83%1 Year PerformanceN/A-1.97%30.34%16.51% TuHURA Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HURATuHURA Biosciences1.4635 of 5 stars$2.22-3.1%$12.67+470.6%N/A$96.97MN/A0.00N/AAnalyst RevisionHigh Trading VolumeZYBTZhengye BiotechnologyN/A$7.43-20.1%N/AN/A$438.65MN/A0.00278Gap DownORKAOruka Therapeutics2.8107 of 5 stars$10.90-6.7%$40.38+270.4%N/A$437.30MN/A0.00N/ASIGASiga Technologies1.4414 of 5 stars$6.19+1.1%N/A-16.1%$437.22M$138.72M9.1340News CoverageOptions VolumeCMPSCOMPASS Pathways1.9196 of 5 stars$2.35-49.2%$17.00+623.4%-54.2%$433.19MN/A0.00120High Trading VolumePGENPrecigen3.961 of 5 stars$1.48+2.1%$6.00+305.4%-7.7%$428.01M$3.92M-2.64190TRMLTourmaline Bio2.6643 of 5 stars$17.02+2.3%$49.33+189.9%+18.9%$427.41MN/A0.0044News CoverageRGNXREGENXBIO4.549 of 5 stars$7.86-6.8%$31.63+302.4%-24.0%$422.85M$83.33M-2.53370Positive NewsPRTCPureTech Health2.604 of 5 stars$17.56+0.7%$45.00+156.3%-28.2%$418.89M$4.83M0.00100News CoverageKMDAKamada3.6761 of 5 stars$7.26+0.8%$14.67+102.0%+58.0%$414.04M$160.95M25.03360ORGOOrganogenesis4.5574 of 5 stars$3.34+3.4%$5.50+64.7%+39.9%$409.74M$482.04M-19.65950Positive News Related Companies and Tools Related Companies ZYBT Competitors ORKA Competitors SIGA Competitors CMPS Competitors PGEN Competitors TRML Competitors RGNX Competitors PRTC Competitors KMDA Competitors ORGO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HURA) was last updated on 6/27/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TuHURA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TuHURA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HURA Stock Free HURA Stock Alerts